Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A review of the drug–drug interactions of the new antiepileptic drug brivaracetam
Epilepsy/Clinical Neurophysiology (EEG)
P4 - (-)
109
Authors/Disclosures
Brian D. Moseley, MD (University of Cincinnati)
PRESENTER
Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences.
No disclosure on file
No disclosure on file
No disclosure on file